Ülke: Malta
Dil: İngilizce
Kaynak: Medicines Authority
PARACETAMOL
Fresenius Kabi Italia S.r.l Via Camagre 41, 37063 Isola della Scala (Vr) , Italy
N02BE01
PARACETAMOL 10 mg/ml
SOLUTION FOR INFUSION
PARACETAMOL 10 mg/ml
POM
ANALGESICS
Licence number in the source country: NOT APPLICAPABLE
Authorised
2021-08-19
1.3.1 SPC, LABELLING AND PACKAGE LEAFLET palen-paracetamolkabi-dcp-Jan 2020 -clean 1 PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL KABI 10 MG/ML SOLUTION FOR INFUSION Paracetamol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any of the side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Paracetamol Kabi is and what it is used for 2. What you need to know before you use Paracetamol Kabi 3. How to use Paracetamol Kabi 4. Possible side effects 5. How to store Paracetamol Kabi 6. Contents of the pack and other information 1. WHAT PARACETAMOL KABI IS AND WHAT IT IS USED FOR This medicine is an analgesic (it relieves pain) and an antipyretic (it lowers fever). It is indicated - for the short-term treatment of moderate pain, especially following surgery, and - for the short-term treatment of fever. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE PARACETAMOL KABI DO NOT USE PARACETAMOL KABI - if you are ALLERGIC (hypersensitive) TO PARACETAMOL or any of the other ingredients of Paracetamol Kabi (listed in section 6). - if you are ALLERGIC (hypersensitive) TO PROPACETAMOL (another pain killer and a precursor of paracetamol). - if you suffer from a SEVERE LIVER DISEASE . WARNINGS AND PRECAUTIONS Talk to your doctor before using Paracetamol Kabi. TAKE SPECIAL CARE WITH PARACETAMOL KABI - if you suffer from a LIVER OR KIDNEY DISEASE , or from ALCOHOL ABUSE . - if you suffer from a inherited liver function disorder called MEULENGRACHT GILBERT'S SYNDROME . - if you suffer from GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. - if you are taking OTHER MEDICINES CONTA Belgenin tamamını okuyun
1.3.1 SPC, LABELLING AND PACKAGE LEAFLET Page 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Paracetamol Kabi 10 mg/ml solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 10 mg paracetamol. Each 10 ml ampoule contains 100 mg paracetamol. Each 50 ml vial or bag contains 500 mg paracetamol. Each 100 ml vial or bag contains 1000 mg paracetamol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for infusion Clear and slightly yellowish solution. The solution is iso-osmotic, and its pH is between 5.0 and 7.0. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Paracetamol Kabi is indicated for: • the short-term treatment of moderate pain, especially following surgery, • the short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Intravenous use. The 100 ml vial or bag is restricted to adults, adolescents and children weighing more than 33 kg. The 10 ml ampoule and the 50 ml vial or bag is restricted to term newborn infants, infants, toddlers and children weighing up to 33 kg. Posology: Dosing based on patient weight (please see the dosing table here below): 1.3.1 SPC, LABELLING AND PACKAGE LEAFLET Page 2 PATIENT WEIGHT DOSE PER ADMINISTRATION VOLUME PER ADMINISTRATION_ _ MAXIMUM VOLUME OF PARACETAMOL KABI 10 MG/ML SOLUTION FOR INFUSION PER ADMINISTRATION BASED ON UPPER WEIGHT LIMITS OF GROUP (ML)*** MAXIMUM DAILY DOSE** ≤ 10 KG* 7.5 mg/kg _ _ 0.75 mL/kg 7.5 mL 30 mg/kg > 10 KG TO ≤ 33 KG 15 mg/kg _ _ 1.5 mL/kg 49.5 mL 60 mg/kg, not exceeding 2 g > 33 KG TO ≤ 50 KG 15 mg/kg _ _ 1.5 mL/kg 75 mL 60 mg/kg, not exceeding 3 g > 50 KG AND WITH ADDITIONAL RISK FACTORS FOR HEPATOTOXICITY 1 g 100 mL 100 mL 3 g > 50 KG AND NO ADDITIONAL RISK FACTORS FOR HEPATOTOXICITY 1 g 100 mL 100 mL 4 g * PRE-TERM NEWBORN INFANTS: No safety and efficacy data are a Belgenin tamamını okuyun